Yuyu Pharma Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.034x

Yuyu Pharma Inc cash flow conversion efficiency. Based on the latest financial reports, Yuyu Pharma Inc (000225) has a cash flow conversion efficiency ratio of 0.034x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.91 Billion ≈ $3.33 Million USD) by net assets (₩146.18 Billion ≈ $99.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000225 market cap for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Yuyu Pharma Inc (2014–2025)

Cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2025. This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yuyu Pharma Inc (000225) stock price for real-time trading data and today's change.

Yuyu Pharma Inc Cash Flow Conversion Ratio Explained

Yuyu Pharma Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency. Review Yuyu Pharma Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
ChowChow Cloud International Holdings Limited NYSE MKT:CHOW	0.044x
Airo Lam limited NSE:AIROLAM	0.083x
Inoviq Ltd AU:IIQ	-0.098x
Silver Viper Minerals Corp V:VIPR	-0.218x
GigaMedia Limited F:GIFN	N/A
VOGO SA PA:ALVGO	0.133x
Lena Lighting S.A. WAR:LEN	-0.024x
Mg Internation PA:ALMGI	-0.026x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2025. Also see how large is Yuyu Pharma Inc's balance sheet for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩140.54 Billion ≈ $95.24 Million	₩15.88 Billion ≈ $10.76 Million	0.113x	-38.84%
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000225 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$13.44 Million

₩19.84 Billion KRW

Market Cap Rank

#26172 Global

#1961 in Korea

Share Price

₩3385.00

Change (1 day)

+1.96%

52-Week Range

₩3320.00 - ₩5250.00

All Time High

₩25149.31